Hospital for Special Surgery, New York Clinical Trials
Sponsors / Hospital for Special Surgery, New York
201 ClinicalTrials.gov entries name Hospital for Special Surgery, New York as the lead sponsor. The portfolio currently includes 31 recruiting studies, 14 active non-recruiting studies, and 128 completed studies. 18 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Cumulative planned enrollment across all listed trials is 39,080 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
201
Total Trials
31
Recruiting
14
Other Active
128
Completed
18
Terminated / Withdrawn
39,080
Total Enrollment
Termination reasons: Other56% · Recruitment17% · Efficacy11% · Regulatory6% · PI/or_Site6% · Safety6%
Recent Terminations
- Post Operative Pain"Unanticipated adverse events occurred in 2 participants"
- NCT05354791 Stopped Mar 2023Ankle Surgery"Retrospective study that the PI decided not to proceed with"
- ALS"Did not meet target enrollment"
- ALS"Did not meet target enrollment"
- Quad Atrophy
- Knee Arthroscopy"Study halted due to COVID-19 pandemic and terminated early per request of principal investigator as Chloroprocaine use in spinal procedures has become incorporated as standard of care at HSS."
- Knee Osteoarthritis"Recruitment was suspended due to the COVID pandemic and it was decided not to resume the study."
- Spinal Fusion"No longer clinically relevant"
- Anxiety"Limited resources"
- Hip Pain"slow enrollment, lack of patients"
Active Trials (14 total)
- NCT00198068
- NCT03332238
- NCT03553186
- NCT03747146
- NCT03841058
- NCT04332471
- NCT04720846
- NCT05058287
- NCT06893302
- NCT06971575
- NCT07552415
- NCT00527839
- NCT02234388
- NCT02257554
- NCT04356612
- NCT05412381
- NCT05675618
- NCT05782335
- NCT06887764
- Knee Pain Chronic PHASE2NCT06800209